Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael Kimerling"'
Autor:
Edine Tiemersma, Susan van den Hof, Gunta Dravniece, Fraser Wares, Yohannes Molla, Yusie Permata, Endang Lukitosari, Mamel Quelapio, Si Thu Aung, Khay Mar Aung, Hoang Thanh Thuy, Vu Dinh Hoa, Merkinai Sulaimanova, Saadat Sagyndikova, Mavluda Makhmudova, Alijon Soliev, Michael Kimerling
Publikováno v:
European Respiratory Review, Vol 28, Iss 153 (2019)
New drugs and shorter treatments for drug-resistant tuberculosis (DR-TB) have become available in recent years and active pharmacovigilance (PV) is recommended by the World Health Organization (WHO) at least during the early phases of implementation,
Externí odkaz:
https://doaj.org/article/b36abbdc62434a659f2154b2d500c756
Autor:
Haileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, Elizabeth L Corbett, Helen Ayles, Kevin P Cain, Alison D Grant, Gavin J Churchyard, Michael Kimerling, Sarita Shah, Stephen D Lawn, Robin Wood, Gary Maartens, Reuben Granich, Anand A Date, Jay K Varma
Publikováno v:
PLoS Medicine, Vol 8, Iss 1, p e1000391 (2011)
BackgroundThe World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably exc
Externí odkaz:
https://doaj.org/article/1a36cecec5394d9fa5cadfa75e46b2b5
Autor:
Francine Matthys, Leen Rigouts, Vinciane Sizaire, Natalia Vezhnina, Maryvonne Lecoq, Vera Golubeva, Françoise Portaels, Patrick Van der Stuyft, Michael Kimerling
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e7954 (2009)
Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated tr
Externí odkaz:
https://doaj.org/article/38515bd0577f470b99ad55673ffdc8ed
Autor:
Matteo, Zignol, Andrea Maurizio, Cabibbe, Anna S, Dean, Philippe, Glaziou, Natavan, Alikhanova, Cecilia, Ama, Sönke, Andres, Anna, Barbova, Angeli, Borbe-Reyes, Daniel P, Chin, Daniela Maria, Cirillo, Charlotte, Colvin, Andrei, Dadu, Andries, Dreyer, Michèle, Driesen, Christopher, Gilpin, Rumina, Hasan, Zahra, Hasan, Sven, Hoffner, Alamdar, Hussain, Nazir, Ismail, S M Mostofa, Kamal, Faisal Masood, Khanzada, Michael, Kimerling, Thomas Andreas, Kohl, Mikael, Mansjö, Paolo, Miotto, Ya Diul, Mukadi, Lindiwe, Mvusi, Stefan, Niemann, Shaheed V, Omar, Leen, Rigouts, Marco, Schito, Ivita, Sela, Mehriban, Seyfaddinova, Girts, Skenders, Alena, Skrahina, Sabira, Tahseen, William A, Wells, Alexander, Zhurilo, Karin, Weyer, Katherine, Floyd, Mario C, Raviglione
Publikováno v:
The lancet infectious diseases
The Lancet. Infectious Diseases
The Lancet. Infectious Diseases
Background In many countries, regular monitoring of the emergence of resistance to anti-tuberculosis drugs is hampered by the limitations of phenotypic testing for drug susceptibility. We therefore evaluated the use of genetic sequencing for surveill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a5e625e1bdc7049c02962bb9ddba0448
https://hdl.handle.net/10067/1520100151162165141
https://hdl.handle.net/10067/1520100151162165141
Autor:
Gerard de Vries, Job van Rest, Bert Wolters, Michael Kimerling, Wieneke Meijer, Henrieke Schimmel, Rob van Hest
Publikováno v:
The European respiratory journal. 48(4)
There is need to collect, analyse and compare TB screening data from migrants in EU countries more systematically http://ow.ly/x2eQ303k2CK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8407310bcea2c5d9ae22b13f1b35bb32
https://pubmed.ncbi.nlm.nih.gov/27694419
https://pubmed.ncbi.nlm.nih.gov/27694419
Publikováno v:
The Lancet. 354:1036
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74965afab68aa6975694934f2fdad9b8
https://doi.org/10.1016/s0140-6736(05)76648-4
https://doi.org/10.1016/s0140-6736(05)76648-4